Numbers and rates* of reported cases† of acute hepatitis C, by state or jurisdiction — United States, 2018–2022
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population. Beginning in 2021, single-race population estimates are used for rate calculations. For prior years, bridged-race population estimates are used.
† Reported confirmed cases. For the case definition, see Acute Hepatitis C.
—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable. The disease or condition was not reportable by law, statue, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.
The capacity of each jurisdiction for notifying CDC of acute hepatitis C cases varies considerably on the basis of laws, resources, and infrastructure for conducting viral hepatitis surveillance. During 2022, acute hepatitis C was not a reportable condition in one state (Alaska), cases were unavailable from one state (Arizona), and no cases were reported by two states (Hawaii and North Dakota).
The national rate of reported acute hepatitis C was 1.5 cases per 100,000 population during 2022, a decrease of over 6% from the rate during 2021. During 2022, Maine had the highest rate of reported cases of acute hepatitis C (6.8 cases per 100,000 population). Florida reported the largest number of cases (n = 1,463) — 30% of all reported acute hepatitis C cases during 2022.
- Figure 3.1. Number of reported cases and estimated infections of acute hepatitis C — United States, 2015–2022
- Figure 3.2. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2021–2022
- Figure 3.3. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2022
- Figure 3.4. Rates of reported cases of acute hepatitis C, by age group — United States, 2007–2022
- Figure 3.5. Rates of reported cases of acute hepatitis C, by sex — United States, 2007–2022
- Figure 3.6. Rates of reported cases of acute hepatitis C, by race/ethnicity — United States, 2007–2022
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C — United States, 2022
- Figure 3.8. Number of newly reported chronic hepatitis C cases by sex and age — United States, 2022
- Figure 3.9. Rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2022
- Table 3.1. Numbers and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2018–2022
- Table 3.2. Numbers and rates of reported cases of acute hepatitis C, by demographic characteristics — United States, 2018–2022
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C — United States, 2022
- Table 3.4. Number of newly reported cases of perinatal hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C, by demographic characteristics — United States, 2022
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 3.8. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022